Search Results - "Argerich, Josep"

  • Showing 1 - 11 results of 11
Refine Results
  1. 1

    Disease-modifying effects of natural Δ9-tetrahydrocannabinol in endometriosis-associated pain by Escudero-Lara, Alejandra, Argerich, Josep, Cabañero, David, Maldonado, Rafael

    Published in eLife (01-01-2020)
    “…Endometriosis is a chronic painful disease highly prevalent in women that is defined by growth of endometrial tissue outside the uterine cavity and lacks…”
    Get full text
    Journal Article
  2. 2

    Unique effect of clozapine on adenosine A2A-dopamine D2 receptor heteromerization by Valle-León, Marta, Casajuana-Martin, Nil, del Torrent, Claudia Llinas, Argerich, Josep, Gómez-Acero, Laura, Sahlholm, Kristoffer, Ferré, Sergi, Pardo, Leonardo, Ciruela, Francisco

    Published in Biomedicine & pharmacotherapy (01-04-2023)
    “…The striatal dopamine D2 receptor (D2R) is generally accepted to be involved in positive symptoms of schizophrenia and is a main target for clinically used…”
    Get full text
    Journal Article
  3. 3
  4. 4
  5. 5

    Design, Synthesis and Characterization of a New Series of Fluorescent Metabotropic Glutamate Receptor Type 5 Negative Allosteric Modulators by Fernández-Dueñas, Víctor, Qian, Mingcheng, Argerich, Josep, Amaral, Carolina, Risseeuw, Martijn D P, Van Calenbergh, Serge, Ciruela, Francisco

    Published in Molecules (Basel, Switzerland) (27-03-2020)
    “…In recent years, new drug discovery approaches based on novel pharmacological concepts have emerged. Allosteric modulators, for example, target receptors at…”
    Get full text
    Journal Article
  6. 6

    Ecto-GPR37: a potential biomarker for Parkinson's disease by Morató, Xavier, Garcia-Esparcia, Paula, Argerich, Josep, Llorens, Franc, Zerr, Inga, Paslawski, Wojciech, Borràs, Eva, Sabidó, Eduard, Petäjä-Repo, Ulla E, Fernández-Dueñas, Víctor, Ferrer, Isidro, Svenningsson, Per, Ciruela, Francisco

    Published in Translational neurodegeneration (26-02-2021)
    “…α-Synuclein has been studied as a potential biomarker for Parkinson's disease (PD) with no concluding results. Accordingly, there is an urgent need to find out…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Unique effect of clozapine on adenosine A 2A -dopamine D 2 receptor heteromerization by Valle-León, Marta, Casajuana-Martin, Nil, Del Torrent, Claudia Llinas, Argerich, Josep, Gómez-Acero, Laura, Sahlholm, Kristoffer, Ferré, Sergi, Pardo, Leonardo, Ciruela, Francisco

    Published in Biomedicine & pharmacotherapy (01-04-2023)
    “…The striatal dopamine D receptor (D R) is generally accepted to be involved in positive symptoms of schizophrenia and is a main target for clinically used…”
    Get full text
    Journal Article
  9. 9

    GPR37 is processed in the N‐terminal ectodomain by ADAM10 and furin by Mattila, S. Orvokki, Tuhkanen, Hanna E., Lackman, Jarkko J., Konzack, Anja, Morató, Xavier, Argerich, Josep, Saftig, Paul, Ciruela, Francisco, Petäjä‐Repo, Ulla E.

    Published in The FASEB journal (01-06-2021)
    “…GPR37 is an orphan G protein‐coupled receptor (GPCR) implicated in several neurological diseases and important physiological pathways in the brain. We…”
    Get full text
    Journal Article
  10. 10

    Cannabidiol negatively modulates adenosine A 2A receptor functioning in living cells by Sánchez-Fernández, Nuria, Gómez-Acero, Laura, Sarasola, Laura I, Argerich, Josep, Chevigné, Andy, Jacobson, Kenneth A, Ciruela, Francisco, Fernández-Dueñas, Víctor, Aso, Ester

    Published in Acta neuropsychiatrica (01-10-2024)
    “…Cannabidiol (CBD) is a phytocannabinoid with great potential in clinical applications. The mechanism(s) of action of CBD require further investigation…”
    Get more information
    Journal Article
  11. 11

    B2R-D2R Interaction in Prolactinomas and Nonfunctional Adenomas: Impact on Dopamine Resistance by Abeledo-Machado, Alejandra, Argerich, Josep, Yaneff, Agustín, Vidal, Noemi, García-Roca, Claudia, Bornancini, Dana, Peña-Zanoni, Milagros, Gironacci, Mariela M, Shayo, Carina, Ciruela, Francisco, Díaz-Torga, Graciela

    Published in Endocrinology (Philadelphia) (30-10-2024)
    “…Abstract Prolactinomas, the most common pituitary-secreting adenomas, can be effectively treated with dopamine D2 receptor (D2R) agonists. However, a subset of…”
    Get full text
    Journal Article